Vistagen Therapeutics (VTGN) Return on Sales [ROS] (2011 - 2026)
Vistagen Therapeutics (VTGN) reported Return on Sales [ROS] of -904.34% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5572.71 percentage points from -6477.05% a year earlier and up 2690.72 percentage points from the prior quarter.
Vistagen Therapeutics (VTGN) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vistagen Therapeutics' Return on Sales [ROS] came in at -2784.33%, up 6448.79 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5683.69%, up 5833.39 percentage points from FY2025.
- Return on Sales [ROS] has a five-year change of -4037.63 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Sales [ROS] came in at -11517.08% in FY2025 (-8413.60 pp), -3103.48% in FY2024 (+23005.77 pp), -26109.25% in FY2023 (-21800.96 pp) and -4308.30% in FY2022 (-2662.24 pp).
- The fiscal Q1 2027 figure ranks as the highest quarterly Return on Sales [ROS] since fiscal Q4 2017.
- Year over year, Return on Sales [ROS] has now increased in each of the last five quarters, with an average year-over-year change of +852.93 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was fiscal Q4 2023 (a gain of 35848.59 percentage points); the low point was fiscal Q4 2022 (a drop of 41395.55 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -3595.05% (Q4 2026), -6450.83% (Q3 2026) and -7772.48% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | -904.34% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -904.34% |
| Mar 31, 2026 | -3,595.05% |
| Dec 31, 2025 | -6,450.83% |
| Sep 30, 2025 | -7,772.48% |
| Jun 30, 2025 | -6,477.05% |
| Mar 31, 2025 | -11,517.08% |
| Dec 31, 2024 | -6,461.54% |
| Sep 30, 2024 | -7,774.32% |
| Jun 30, 2024 | -14,441.67% |
| Mar 31, 2024 | -6,926.22% |
| Dec 31, 2023 | -1,918.25% |
| Sep 30, 2023 | -2,260.00% |
| Jun 30, 2023 | -3,499.00% |
| Mar 31, 2023 | -6,953.98% |
| Dec 31, 2022 | -5,425.83% |
| Sep 30, 2022 | -1,958.49% |
| Jun 30, 2022 | -6,376.36% |
| Mar 31, 2022 | -42,802.56% |
| Dec 31, 2021 | -2,943.85% |
| Sep 30, 2021 | -3,575.42% |
Vistagen Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();